ENXTPA:ALERSBiotechs
Eurobio Scientific (ENXTPA:ALERS) Margin Improvement To 2.9% Tests Bearish Earnings Narratives
Eurobio Scientific Société anonyme (ENXTPA:ALERS) has reported FY 2025 first half revenue of €80.8 million and basic EPS of €0.23, setting the tone for a year where margins and earnings quality are firmly in focus for investors. The company has seen revenue move from €73.3 million in the first half of 2024 to €81.5 million in the second half of 2024 and then to €80.8 million in the latest period, while basic EPS shifted from €0.40 to effectively flat and now €0.23, against a backdrop of a...